Penn Medicine Provider
Medical Oncology
Naomi B. Haas, MD
5.0
(520)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West

About me

  • Director, Prostate and Kidney Cancer Program
  • Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Northeastern Ohio University - College of Medicine
  • Residency: Abington Memorial Hospital
  • Fellowship: Fox Chase Cancer Center

What my patients think about me

Average Rating
5.0

523 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
4.0
4.0
pleasant visit
May 2025
5.0
5.0
dr. haas is world class
May 2025
5.0
5.0
she was friendly and courteous
April 2025
5.0
5.0
because she answered all my questions and any concerns that i had

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Haas is a Penn Medicine physician.

Qualifications and experience

My research

Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ, Lewis JD Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. , Diabetes Care, 37(7): 2014 ,1910-7


Haas NB, Quirt I, Hotte S, McWhirter E, Polintan R, Litwin S, Adams PD, McBryan T, Wang L, Martin LP, vonMehren M, Alpaugh RK, Zweibel J, Oza A Phase II trial of Vorinostat in advanced melanoma , Invest New Drugs, 32(3): 2014,526-34


Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, Schöffski P, Scheffold C, Weitzman AL, Hussain M. Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial. , J Clin Oncol, 31(4): 2013,412-9


Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R. Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma , J Clin Oncol, 31(2): 2013,181-6


Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. , Int J Radiat Oncol Biol Phys, 83(5): 2012,1493-9


Haas Naomi B, Lin Xinyi, Manola Judith, Pins Michael, Liu Glenn, McDermott David, Nanus David, Heath Elisabeth, Wilding George, Dutcher Janice A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. , Medical oncology (Northwood, London, England), 29(2): 2012,761-7


Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala N, Bekelman JE Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. , Int J Radiat Oncol Biol Phys, 83(1): 2012,8-15


Swisher-McClure Samuel, Pollack Craig E, Christodouleas John P, Guzzo Thomas J, Haas Naomi B, Vapiwala Neha, Bekelman Justin E Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. , International journal of radiation oncology, biology, physics, 83(1): 2012,8-15


Yeboa DN, Guzzo T, Mitra N, Christodouleas JP, Haas NB, Vapiwala N, Armstrong K, Bekelman JE. Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. , Urology: 2011


Yeboa Debra Nana, Guzzo Thomas, Mitra Nandita, Christodouleas John P, Haas Naomi B, Vapiwala Neha, Armstrong Katrina, Bekelman Justin E Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. , Urology, 78(5): 2011,1107-13